VivoPower PLC VIVO
1.83 USD +0.31 (+20.39%)
At closeNov 6, 2026, 5:47 AM EST
1.88 +0.05 +2.73%
Pre-market · Nov 6, 5:47 AM ET
1.56 Day range 1.87
1.20 52-week range 6.86
- YTD
- -19.38%
- 1 year
- -42.27%
News
prnewswire.com Flyte Aviation Executes Letter of Intent to Sell Cardiology Assets Proposed Sale to include VIVO and LockeT Cardiac Electrophysiology product lines Divestiture would Complete the Company's Planned Transition to Pure-Play Tech-Enabled Private Aviation The Proposed…
globenewswire.com VivoPower Reports Unaudited First Quarter Fiscal Year 2027 Results with Revenue of US$6.8 Million, Net Profit of US$0.6 Million and Positive Operating Cash Flow of US$2.1 Million Revenue of US$6.5 million, or 95.5% generated from the data center in Mo i Rana, Norway Net profit of US$0.6 million, compared with a net loss of US$7.4 million in Q1 FY2026 EBITDA of US$0.8 million…
benzinga.com Noble Capital Markets Maintains Outperform on VivoPower, Maintains $10 Price Target Noble Capital Markets analyst Michael Kupinski maintains VivoPower (NASDAQ:VIVO) with a Outperform and maintains $10 price target.
globenewswire.com VivoPower Reports FY2026 Results Including a Partial-Period Contribution from Mo i Rana Data Center Financial results for FY2026 are not reflective of full-year contribution from the Mo i Rana Data Center business
globenewswire.com Catheter Precision Announces New FDA 510(k) Clearance for its VIVO System, Enabling Use in a Broader Patient Population FORT MILL, S.C., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, a wholly owned subsidiary of Flyte Aviation, Inc. (NYSE American: VJET), today announced that its VIVO system has received FDA…
benzinga.com Top 3 Utilities Stocks Which Could Rescue Your Portfolio This Month Deep Fission, Emera and VivoPower are oversold utilities stocks with RSI readings near or below 30, presenting potential buying opportunities.